Evidence map›Paper›PMID 35808830›Full record

ArticleClinical and translational medicine2022

WDR62 variants contribute to congenital heart disease by inhibiting cardiomyocyte proliferation.

Lili Hao, Jing Ma, Feizhen Wu, Xiaojing Ma, Maoxiang Qian, Wei Sheng, Tizhen Yan, Ning Tang, Xin Jiang, Bowen Zhang and 8 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Defects inFrontiers in genetics · 2026
    Article
  4. Article
  5. Current and future diagnostics of congenital heart disease (CHD).Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Zebrafish Congenital Heart Disease Models: Opportunities and Challenges.International journal of molecular sciences · 2024
    Review
  11. Article
  12. Discovery ofBiology · 2023
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 2 countries.

Lili HaoShanghai Key Laboratory of Birth Defects, Children's Hospital of Fudan University, Shanghai, China.
Jing MaENT institute, Department of Facial Plastic and Reconstructive Surgery, Eye & ENT Hospital of Fudan University, Shanghai, China.ORCID 0000-0001-9074-8570
Feizhen WuLaboratory of Epigenetics, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Xiaojing MaShanghai Key Laboratory of Birth Defects, Children's Hospital of Fudan University, Shanghai, China.
Maoxiang QianShanghai Key Laboratory of Birth Defects, Children's Hospital of Fudan University, Shanghai, China.
Wei ShengShanghai Key Laboratory of Birth Defects, Children's Hospital of Fudan University, Shanghai, China.
Tizhen YanDepartment of Medical Genetics, Department of Clinical Laboratory, Liuzhou Maternity and Child Healthcare Hospital, Liuzhou, Guangxi, China.
Ning TangDepartment of Medical Genetics, Department of Clinical Laboratory, Liuzhou Maternity and Child Healthcare Hospital, Liuzhou, Guangxi, China.
Xin JiangMedical Laboratory of Nantong ZhongKe, Nantong, Jiangsu.
Bowen ZhangKey Laboratory of Metabolism and Molecular Medicine, Ministry of Education, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Deyong XiaoKey Laboratory of Metabolism and Molecular Medicine, Ministry of Education, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Yanyan QianShanghai Key Laboratory of Birth Defects, Children's Hospital of Fudan University, Shanghai, China.
Jin ZhangKey Laboratory of Metabolism and Molecular Medicine, Ministry of Education, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Nan JiangKey Laboratory of Metabolism and Molecular Medicine, Ministry of Education, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Wenhao ZhouShanghai Key Laboratory of Birth Defects, Children's Hospital of Fudan University, Shanghai, China.
Weicheng ChenShanghai Key Laboratory of Birth Defects, Children's Hospital of Fudan University, Shanghai, China.
Duan MaShanghai Key Laboratory of Birth Defects, Children's Hospital of Fudan University, Shanghai, China.
Guoying HuangShanghai Key Laboratory of Birth Defects, Children's Hospital of Fudan University, Shanghai, China.ORCID 0000-0001-9887-8978
Children's Hospital of Fudan University · CNShanghai Medical College of Fudan University · CNLiuzhou Maternal and Child Health Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNEye & ENT Hospital of Fudan University · CNFudan University · CNNantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCongenital heart disease (CHD) is the most common birth defect and has high heritability. Although some susceptibility genes have been identified, the genetic basis underlying the majority of CHD cases is still undefined.

methodsA total of 1320 unrelated CHD patients were enrolled in our study. Exome-wide association analysis between 37 tetralogy of Fallot (TOF) patients and 208 Han Chinese controls from the 1000 Genomes Project was performed to identify the novel candidate gene WD repeat-containing protein 62 (WDR62). WDR62 variants were searched in another expanded set of 200 TOF patients by Sanger sequencing. Rescue experiments in zebrafish were conducted to observe the effects of WDR62 variants. The roles of WDR62 in heart development were examined in mouse models with Wdr62 deficiency. WDR62 variants were investigated in an additional 1083 CHD patients with similar heart phenotypes to knockout mice by multiplex PCR-targeting sequencing. The cellular phenotypes of WDR62 deficiency and variants were tested in cardiomyocytes, and the molecular mechanisms were preliminarily explored by RNA-seq and co-immunoprecipitation.

resultsSeven WDR62 coding variants were identified in the 237 TOF patients and all were indicated to be loss of function variants. A total of 25 coding and 22 non-coding WDR62 variants were identified in 80 (6%) of the 1320 CHD cases sequenced, with a higher proportion of WDR62 variation (8%) found in the ventricular septal defect (VSD) cohort. WDR62 deficiency resulted in a series of heart defects affecting the outflow tract and right ventricle in mouse models, including VSD as the major abnormality. Cell cycle arrest and an increased number of cells with multipolar spindles that inhibited proliferation were observed in cardiomyocytes with variants or knockdown of WDR62. WDR62 deficiency weakened the association between WDR62 and the cell cycle-regulated kinase AURKA on spindle poles, reduced the phosphorylation of AURKA, and decreased expression of target genes related to cell cycle and spindle assembly shared by WDR62 and AURKA.

conclusionsWDR62 was identified as a novel susceptibility gene for CHD with high variant frequency. WDR62 was shown to participate in the cardiac development by affecting spindle assembly and cell cycle pathway in cardiomyocytes.

Indexed as

Cell Cycle ProteinsHeart Defects, CongenitalHeart Septal Defects, VentricularMyocytes, CardiacTetralogy of FallotAnimalsAurora Kinase ACell DivisionExomeHumansMiceNerve Tissue ProteinsZebrafishAurora Kinase ACell Cycle ProteinsNerve Tissue ProteinsWDR62 protein, humanWDR62 protein, mousecardiomyocyte proliferationcell cyclecongenital heart diseasespindle assemblythe WDR62 gene

Identifiers

PMID35808830
PMCPMC9270576
OpenAlexW4284989593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.